StonvexLoading…
StonvexStonvexStonvexCore line items from CXT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.66B | $1.49B | $1.39B | $1.34B |
Operating Income | $246.70M | $268.80M | $286.80M | $301.30M |
Net Income | $145.10M | $184.10M | $188.30M | $204.90M |
EPS (Diluted) | $2.50 | $3.19 | $3.28 | $3.61 |
Total Assets | $3.12B | $2.39B | $2.13B | $2.13B |
Total Liabilities | $1.86B | $1.32B | $1.17B | $1.35B |
Cash & Equivalents | $233.80M | $165.80M | $227.20M | $230.70M |
Free Cash Flow OCF − CapEx | $198.30M | $168.70M | $245.20M | $284.70M |
Shares Outstanding | 57.44M | 57.20M | 56.90M | 56.33M |